产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 药品制剂 Iohexol Injecti...

Iohexol Injection

2026-02-27
北京市

产品详情

Iohexol Injection
心脑血管及循环系统类制剂
Iohexol Injection
(1) 20 ml: 6 gI (2) 50 ml: 15 gI (3) 75 ml
5000
100000
T/T, L/C
Negotiation
中国,北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲

产品描述

Iohexol Injection is a non-ionic Contrast Media. Compared with a traditional ionic Contrast Media, Iohexol Injection has the excellent molecular structure, it has greatly improved safety and significantly reduced adverse reactions, also it has excellent clinical feedback and good imaging results. In 1998, Iohexol Injection was launched as Beilu's 1st iodinated Contrast Media.

Product name: Iohexol Injection

Generic name: Iohexol Injection

Type: Injectable Contrast Media for CT/X-ray

Ingredients: Iohexol

Specification:

(1) 20 ml: 6 gI         (2) 50 ml: 15 gI

(3) 75 ml: 22.5 gI    (4) 100 ml: 30 gI

(5) 20 ml: 7 gI         (6) 50 ml: 17.5 gI

(7) 100 ml: 35 gI

Administration: For injection or oral use

Adverse reactions: See the details from the package insert

Shelf life: 36 months

北京北陆药业股份有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

Founded in 1992, Beilu is mainly engaged in the research & development, production and sales of pharmaceutical products. It is high-tech innovation company with core competence in the Contrast Media domestic. It has around 650 employees with 0.82 Bn/¥ revenue in 2019. Beilu provides complete Contrast Media products suitable for X-Ray and Magnetic Resonance Imaging (MRI), and it is the leading manufacturer in the Contrast Media field in China. It is one of the 1st batches of listed enterprises in GEM of SZSE (Ticker: 300016.SZ) in China.   Beilu's main products are Contrast Media, Anti-anxiety traditional Chinese medicine, and Anti-diabetic drugs to benefit people and improve their quality of life. Contrast Media are widely used to improve pictures of the inside of the body produced by X-rays, computed tomography (CT), magnetic resonance (MR) imaging, etc. Anti-anxiety traditional Chinese medicine is the original product with Chinese patent to contribute to improving the physical and mental status. And Anti-diabetic drugs are hypoglycemic drugs for the treatment of type 2 diabetes.
业务类型:
成立日期:
年营业额:
主营产品类别: